SL

Sonja Leyrer

BA Bavarian Nordic A/S: 26 patents #3 of 78Top 4%
📍 Birkenfeld, DE: #20 of 1,442 inventorsTop 2%
Overall (All Time): #147,140 of 4,157,543Top 4%
27
Patents All Time

Issued Patents All Time

Showing 1–25 of 27 patents

Patent #TitleCo-InventorsDate
9109233 Recombinant poxvirus expressing homologous genes inserted Paul Howley 2015-08-18
8815501 Flavivirus NS1 subunit vaccine Paul Howley, Mary Jane Cardosa, Magdeline Sia Henry Sum 2014-08-26
8741308 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA) Paul Howley 2014-06-03
8741653 Single recombination system and methods of use Katja Fischer 2014-06-03
8435535 Fusion proteins of HIV regulatory/accessory proteins Paul Howley, Eva Felder 2013-05-07
8435543 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA) Paul Howley 2013-05-07
8414900 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA) Paul Howley 2013-04-09
8389275 Fusion proteins of HIV regulatory/accessory proteins Paul Howley, Eva Felder 2013-03-05
8323661 Method for generating a stable recombinant modified vaccinia virus ankara (MVA) comprising human immunodeficiency virus (HIV) genes inserted into one or more intergenic regions (IGRs) Paul Howley, Paul Chaplin, Eva Felder 2012-12-04
8309326 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA) Paul Howley 2012-11-13
8309098 Recombinant modified vaccinia ankara (MVA) virus containing heterologous DNA inserts encoding human immunodeficiency virus (HIV) antigens inserted into one or more intergenic regions (IGRs) Paul Howley, Paul Chaplin, Eva Felder 2012-11-13
8288125 Intergenic regions as insertion sites in the genome of modified vaccinia virus Ankara (MVA) Paul Howley 2012-10-16
8198088 Method for introducing human immunodeficiency virus nucleotide sequences into a cell utilizing modified vaccinia virus Ankara (MVA) recombinants comprising HIV genes inserted into one or more intergenic regions (IGRs) Paul Howley, Paul Chaplin, Eva Felder 2012-06-12
8197822 Method for the production of human immunodeficiency virus (HIV) proteins utilizing modified vaccinia virus ankara (MVA) recombinants comprising HIV genes inserted into one or more intergenic regions (IGRs) Paul Howley, Paul Chaplin, Eva Felder 2012-06-12
8147839 Fusion proteins of HIV regulatory/accessory proteins Paul Howley, Eva Felder 2012-04-03
8143054 Fusion protein of HIV regulatory/accessory proteins Paul Howley, Eva Felder 2012-03-27
8137931 Fusion proteins of HIV regulatory/accessory proteins Paul Howley, Eva Felder 2012-03-20
8034354 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA) Paul Howley 2011-10-11
8029800 Recombinant modified vaccinia virus ankara (MVA) comprising human immunodeficiency virus (HIV) genes inserted into one or more intergenic regions (IGRs) Paul Howley, Paul Chaplin, Eva Felder 2011-10-04
8021669 Methods for inducing an immune response in a host comprising administering modified vaccinia virus ankara (MVA) recombinants comprising human immunodeficiency virus (HIV) genes inserted into one or more intergenic regions (IGRs) Paul Howley, Paul Chaplin, Eva Felder 2011-09-20
7964374 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA) Paul Howley 2011-06-21
7816508 Promoters for expression in modified vaccinia virus Ankara 2010-10-19
7759116 MVA virus vector expressing dengue NS1 protein Paul Howley, Mary Jane Cardosa, Magdeline Sia Henry Sum 2010-07-20
7550147 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA) Paul Howley 2009-06-23
7501127 Intergenic regions as novel sites for insertion of HIV DNA sequences in the genome of Modified Vaccinia virus Ankara Paul Howley, Paul Chaplin, Eva Felder 2009-03-10